Sarasota, FL -- (SBWIRE) -- 01/22/2019 -- Major participants in the organ preservation market comprise BioTime, Inc., BioLife Solutions, Inc., CryoLife, Inc., Claris Lifesciences Limited, Lifeline Scientific, Bristol-Myers Squibb, Teva Pharmaceutical Industries Ltd., Dr. Franz Köhler Chemie GmbH, ToleroTech, Inc., and Preservation Solutions, Inc. among others. These players are said to tower the development of organ preservation market in the years to come.

Request Free Sample Report Keyword @ https://www.zionmarketresearch.com/sample/organ-preservation-market

According to analyst at Zion Market Research, the global organ preservation market added up for USD 163.32 Million in 2016 and is likely to cross USD 262.06 Million by end of 2022, developing at a CAGR of almost 8.2% from 2017 to 2022.

Rising Aged Population All Over The World Paired With Increasing Multi-Organ Breakdown Incidences Likely To Bolster Organ Preservation Market

The major boosters for organ preservation market comprise increasing solid organ transplantation processes, as per analyst at Zion Market Research. Moreover, rising aged population all over the world paired with increasing multi-organ breakdown incidences is also likely to bolster organ preservation market in years to come. In addition to this, rising government initiatives to support organ donation will also power the development of organ preservation market. On the other hand, limited scope at the level of end users and the high price of purchase are likely to hinder the growth of organ preservation market in coming years. Despite these limitations, R&D in the organ preservation market is likely to be a catalyst for organ preservation market in the near future. For example, in July 2015, UW Hospital invented a new organ preservation method that can replace UW Solution, thereby towering the organ preservation market.

To Rising Number Of Organ Transplants And Favorable Reimbursements Cases To Tower The Global Organ Preservation Market In North America

Based on organ type, the global organ preservation market is divided into lung, kidneys, heart, liver, and other organs. Preservation of kidney added up for the biggest share in organ preservation in 2016 due to the rising elderly population paired with rising occurrence of kidney failures. According to National kidney foundation, over 80% of all people who get therapy for kidney failure are in prosperous nations with worldwide access to large elderly populations and health care.

Download Free PDF Research Report Brochure @ https://www.zionmarketresearch.com/requestbrochure/organ-preservation-market

In terms of regions, in 2016 North America ruled the organ preservation market. The growth of organ preservation market in this area is credited to rising number of organ transplants and favorable reimbursements cases within some areas in Canada. Europe is likely to grab the second spot in organ preservation market in coming years due to technological advancements and a considerable contribution from Spain. Organ preservation market in Asia Pacific is likely to see the quickest development rate in the near future owing to rising per capita expenditure on healthcare.

The global organ preservation market is segmented as follows:

By Technique

Static Cold Storage (SCS)
Hypothermic Perfusion Preservation (HPP)
Others

By Preservation Solution

Viaspan
Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution
Renograf
Perfadex
Human bioSystem (HBS) Solution
Lifor
Others

By Organ Type

Kidneys
Lung
Liver
Heart
Others

This review is based on a report by Zion Market Research, titled "Organ preservation Market"- Report at http://www.zionmarketresearch.com/report/organ-preservation-market

By Region

North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa